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Measure Yourself Concerns and Wellbeing (MYCaW) is a patient-centred 
questionnaire that allows cancer patients to identify and quantify the severity of their 
‘Concerns’ and Wellbeing, as opposed to using a pre-determined list. MYCaW 
administration is brief and aids in prioritising treatment approaches. Our goal was to 
assess the convergent validity and responsiveness of MYCaW scores over time, the 
generalisability of the existing qualitative coding framework in different  
complementary and integrative healthcare settings and content validity. 
Methods 
Baseline and 6-week follow-up data (n=82) from MYCaW and FACIT-SpEx 
questionnaires were collected for a service evaluation of the ‘Living Well With The 
Impact of Cancer’ course at Penny Brohn Cancer Care. MYCaW construct validity 
was determined using Spearman's Rank Correlation test, and responsiveness indices 
assessed score changes over time. The existing qualitative coding framework was 
reviewed using a new dataset (n=158) and coverage of concern categories compared 
to items of existing outcome measures. 
Results 
Good correlation between MYCaW and FACIT-SpEx score changes were achieved 
(r= -0.57, p≥0.01). MYCaW Profile and Concern scores were highly responsive to 
change: SRM=1.02 and 1.08; effect size=1.26 and 1.22. MYCaW change scores 
showed the anticipated gradient of change according to clinically relevant degrees of 
change. Categories including ‘Spirituality’, ‘weight change’ and ‘practical concerns’ 
were added to the coding framework to improve generalisability. 
Conclusions 
MYCaW scores were highly responsive to change, allowing personalized patient 
outcomes to be quantified; the qualitative coding framework is generalisable across 
different oncology settings and has broader coverage of patient-identified concerns 
compared with existing cancer-related patient-reported outcome measures. 
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Developments in complementary and integrative medicine (CIM), particularly in 
relation to cancer treatment, have led to a steady growth in the number of health care 
centres that are providing complementary therapy-based supportive care for people 
with cancer and their supporters/carers. For example, in the United States and Canada, 
57 of the most highly esteemed academic medical centres and affiliated centres have 
integrative medicine clinics [1].  
 
The use of complementary and integrative approaches to cancer treatment and patient 
care acknowledge the importance of treating the whole person as opposed to just the 
physical disease [2]. Often, modalities such as massage therapy, counselling, 
nutrition, acupuncture or herbal therapy are used to support people through their 
treatment, recovery and prevention of recurrence, and to improve their quality of life. 
This shift in the health paradigm means there is a need to capture all outcome data 
that is relevant to patients, including psychological, social and spiritual outcome data 
in addition data such as recurrence, survival and tumor size [3-5]. The focus on the 
individual within the whole person framework also underlines the importance of 
understanding what concerns are most important for the patient, to inform clinical 
practice and to accurately and effectively document how a patient benefits from 
complementary and integrative cancer care [6]. The increased use of patient reported 
outcome measures (PROMs) represents a shift towards documenting outcomes from 
the patients’ perspective versus that of a clinician or researcher. Most PROMs used in 
cancer research, however, do not list all items deemed important to patients, or use 
variations in descriptions of item [7, 8]. Inclusion of PROMs in routine clinical 
practice therefore requires careful consideration [9]. The BraveNet Collaboration has 
conducted extensive work to develop PROMs that reflect the patients’ experience of 
integrative medicine [10], however, there is no validated PROM specific to 
complementary and integrative cancer care.  
 
 
The Measure Yourself Concerns and Wellbeing (MYCaW) PROM was developed in 
the United Kingdom (UK), is appropriate for use with patients with all types of cancer 
diagnosis and can also be used with supporters/carers [11]. It is used by integrative 
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cancer centres and cancer support centres in the UK, United States (US), Canada and 
Israel [12-16] and takes approximately two minutes to complete. 
 
MYCaW allows people to identify and score the severity of up to two of their most 
pressing concerns, at the time of their first consultation. This is in contrast to most 
other measures, which ask people to score a pre-determined list of items. The patient 
also rates their overall Wellbeing. After a set number of treatments or a set period of 
time, people independently rescore their initial Concerns and Wellbeing on the 
follow-up MYCaW form. The difference in scores describes the degree of 
improvement, or deterioration. Open-ended questions on the follow-up form also 
capture qualitative data on what people feel is most important about the centre/service 
and anything they have done in addition to receiving complementary care which they 
feel has influenced their health. A key advantage of the MYCaW is that it ensures 
whatever is relevant to the patient is captured in an evaluation, in a way that is not 
possible with a predetermined list of items. MYCaW can easily be integrated within 
an existing documentation system and on-going collection of MYCaW data has been 
shown to help a centre/ service provider to audit or evaluate its service and capture the  
patients’ perspective [13,15,18,19]. 
 
MYCaW also captures qualitative data and has an accompanying qualitative coding 
framework which was validated to allow for standardised analysis of MYCaW 
data[20]. This is important for developing the evidence base in this area. MYCaW 
data can be analysed to identified other variables which are relevant in statistical 
analysis of quantitative data, which is important in the development of comparative 
effectiveness research [21]. Discussion on how to report and combine the change 
scores and qualitative MYCaW data is reported in Seers et al [17].  
 
Whilst extensive effort was previously put into developing a comprehensive coding 
framework, the framework is only based on UK data and therefore the generalizability 
of the framework within difference CIM settings is unclear. Furthermore, the 
responsiveness of the MYCaW Concern and Wellbeing scores has not yet been 
analysed. It is therefore important to determine the extent to which the MYCaW 





The aim of this paper is to report a preliminary assessment of the responsiveness, 
generaliz, content and convergent validity of MYCaW, including (a) an analysis of 
the responsiveness of MYCaW score changes as compared a widely used and 
validated tool  (b)  generalizability via an analysis of the use of MYCaW across 
different CIM health care settings  in different countries  and (c)  content validity via 
a literature search to determine any outcomes that are being captured as MYCaW 
concerns but are not commonly represented within other Health Related Quality of 

















Data were collected as part of a service evaluation of 171 cancer patients and their 
supporters/carers attending Living Well with the Impact of Cancer courses at Penny 
Brohn Cancer Care (PBCC), between August 2011 and January 2012 [19]. MYCaW 
was administered before patients started their course and again 6 weeks later.  Patients 
were asked to write down their 2 main Concerns and score these on a scale of 0 (best 
if could be) to 6 (worst it could be).  Patients also rated their wellbeing using the same 
scale. MYCaW takes approximately 2 minutes to complete at follow-up.  More details 
on MYCaW administration can be found in other studies [19, 20].  These data were 
used to assess the responsiveness of the change in MYCaW scores and to review the 
categories of the qualitative coding framework.  Ethical approval was gained from the 
University of Westminster Research Ethics Committee. 
 
Assessment of responsiveness of MYCaW 
MYCaW score changes from eligible participants (n=82) who had data recorded at 
baseline and at the 6 week follow-up time-point, for both MYCaW and Functional 
Assessment of Chronic Illness Therapy Questionnaire with an additional spiritual 
subscale (FACIT-SpEx) [22] were analyzed.  FACIT-SpEx is a HRQL PROM 
specific to cancer patients; it is responsive to change, valid and reliable in clinical and 
observational settings [23]. A core of 27 questions measure Physical, Social/Family, 
Emotional and Functional Wellbeing relating to cancer therapy. The Extended 
Spiritual subscale (SpEx) encompasses a further 23 items which relate to religious 
and non-religious aspects of spiritual Wellbeing. Hence a total of 50 items assess 
HRQL. For each item participants can select either 'Not at all', 'A little bit', 
'Somewhat', 'Quite a bit' or 'Very much' and the higher the score, the better the HRQL 
of the patient. 
 
Validity and responsiveness were measured using a similar approach employed in the 
validation of the Measure Yourself Medical Outcomes Profile (MYMOP), a sister 
questionnaire developed for general practice [24,25]. To determine convergent  
validity, MYCaW scores were compared to FACIT-SpEx scores. MYCaW Profile 
scores and FACIT-SpEx total scores at baseline were analysed using Spearman's rank 
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correlation (based on non-parametric distribution of scores at baseline), with the aim 
of achieving a negative correlation coefficient of r ≥ 0.3 (based on data from 
Paterson[24]).  
 
A combination of distribution and anchor-based methods have been used to determine 
clinically important change in FACIT scores [26]. Thus FACIT-SpEx was a good 
candidate to use as an anchor to determine when a clinically relevant change had 
occurred. The minimal important difference (MID) for FACIT-SpEx scores were 
calculated based on a change of between 0.15 and 0.25 points per item [26], hence 
clinically relevant improvement was set at 7.5 to 12.5 points. A substantial clinically 
relevant change was deemed any score change of 12.6 points or greater. Change could 
be improvement or deterioration, hence 5 mutually exclusive change categories were 
developed for the purpose of analysis: substantial improvement (≥ +12.6); clinically 
relevant improvement (+7.5 to +12.5); stable (-7.4 to +7.4); clinically relevant 
deterioration (-7.5 to -12.5); substantial deterioration (≥ -12.6).  
 
Mean change scores for MYCaW and FACIT-SpEx were calculated by subtracting 
the baseline score from the 6-week follow-up score. Standardized response mean 
(SRM), and the effect size (ES) were calculated for MYCaW and FACIT-SpEx data 
as a whole group.  
 
Participant data was then grouped using the change categories determined by the 
FACIT-SpEx (described above) and responsiveness indices including T-statistic, 
Guyatt’s responsiveness statistic (GRS), standardized response mean (SRM), and the 
effect size (ES) were calculated for MYCaW data in each change category. Due to the 
small number of participants with clinically relevant deterioration (n=2), meaningful 
analysis could not be carried out for this category. 
 
Determining generalisability of the qualitative analysis framework for MYCaW 
The existing qualitative framework was developed using data from patients from 3 
locations in the United Kingdom who were using the National Health Service (NHS) 
as their primary healthcare provider [20]. For this study, MYCaW Concerns data from 
a further 171 participants in the PBCC Living Well evaluation [19] and 158 
participants cared for at the Ottawa Integrative Cancer Centre (OICC), were analysed 
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to determine the generalizability of the framework and whether any new concerns had 
emerged that warranted inclusion. The OICC is a not-for-profit treatment and research 
centre in Canada offering CIM care to anyone affected by cancer. All people 
receiving care at the OICC are asked to complete the MYCaW questionnaire as part 
of an outcomes evaluation. Concerns data collected at PBCC and OICC were coded 
using the existing framework. Through a constant comparative method potential new 
concern categories and amendments to existing categories were suggested by either 
MP, RJ, HS or LW. Changes to the established framework were only made if 
consensus of opinion was reached, which were accompanied by corresponding 




To assess if any concerns captured on MYCaW were not represented on FACIT-SpEx 
and vice versa, an in-depth comparison was carried out between each item from 
FACIT-SpEx and each category listed in the MYCaW qualitative analysis framework. 
MYCaW Concerns that were not covered on FACIT-SpEx were then searched for on 
other HRQL PROMs. An electronic literature search of MEDLINE, Cochrane 
Database of Systematic Reviews and CINAHL databases, from 2000 to September 
2013 was conducted.  The search strategy included the following keywords or their 
combinations: ‘quality of life questionnaires’, ‘cancer patients’, ‘cancer survivors’, 
‘measures’, and ‘scales’. The search was limited to studies in English and Spanish 
languages. Instruments were included in the review if they were validated, used in 
cancer studies and their description and psychometric properties were reported in a 
cancer population with a varying number of cancer survivor years. Each instrument 




                                                        







Assessment of responsiveness 
A total of 171 participants were recruited into the PBCC service evaluation and 
provided baseline data. Of these, 82 participants had complete data at baseline and 6 
week follow-up for MYCaW and FACIT-SpEx and were included in the calculations 
of responsiveness. 77% of participants were female, 33% were male. Ages ranged 
from 18yrs to > 80yrs and the majority were aged between 51-60yrs (35%). A range 
of cancer types were represented including breast (54%), bowel (10%) and 
gynaecological (7%). Fifty one percent of participants were undergoing primary 
treatment, 21% had completed treatment and 19% had metastatic cancer.  
 
Convergent validity 
There was a high correlation coefficient of baseline MYCaW Profile scores and the 
total FACIT-SpEx scores (r= - 0.57, p≥.01), hence making FACIT-SpEx a suitable 
HRQL measure to use as an anchor when assessing responsiveness of MYCaW.  
 
Responsiveness 
The Concerns and Profile change scores of MYCaW all showed a high SRM and ES 
(Table 1). The MYCaW Wellbeing score was not as sensitive to change as the other 
MYCaW scores, although still showed a moderate level of sensitivity to change. The 
SRMs for MYCaW are highly comparable to those of MYMOP [24,25]. Overall, the 
FACIT-SpEx scores were not as responsive as the MYCaW scores. The highest 
responsiveness scores on FACIT-SpEx were for Emotional Wellbeing, Spiritual 
Wellbeing and the total score.  
 
 
Insert Table 1 here 
 
When the MYCaW data are stratified according to degree of change on the FACIT-
SpEx (see Table 2), there is an anticipated gradient of change for the Wellbeing score 
and to a lesser degree the Concern scores as well. When there was a substantial 
improvement on the FACIT-SpEx, the highest score changes were seen in each of the 
MYCaW questions. The MYCaW scores tended to decrease as the degree of change 




Insert Table 2 here 
 
Comparable with the change scores in Table 2, the responsiveness indices for 
MYCaW were also influenced by the FACIT-SpEx categories of change (see Table 
3). All the indices were larger for participants who had a “substantial improvement” 
on FACIT-SpEx than those who had a “substantial deterioration”. For example, the 
Guyatt response score for MYCaW Concern 1, was 1.28 for the “substantial 
improvement” category, compared to just 0.45 for the “substantial deterioration” 
category. The gradient was consistent across the other categories apart from those 
participants who were “stable” on FACIT-SpEx, with the responsiveness indices 
being consistently higher, rather than lower, than those in the “clinically relevant 
improvement” category. There were not enough participants in the “clinically relevant 
deterioration” category to carry out meaningful analysis. Responsiveness scores for 
Wellbeing were consistently smaller than for the Concern scores across all of the 
responsiveness indices used. This is comparable to the responsiveness scores for 
MYMOP [24,25].  
 
Insert Table 3 here
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Determining the Generalizability of the MYCaW Qualitative Coding Categories 
Overall, the MYCaW coding framework was deemed representative of Concerns data 
collected across PBCC and OICC, however, consensus of opinion was reached on 
several amendments, which reflect new categories to report specific concerns, or 
clarifications to the names and descriptions of categories to make the framework 
generalizable to other health care settings.   Table 4 presents the changes made to the 
qualitative analysis guidelines for MYCaW. 
 
Insert table 4 here 
 
MYCaW qualitative codes were compared to FACIT-SpEx to map similarities. 
Eleven codes were remaining after mapping to FACIT-SpEx, these were mostly 
practical based concerns i.e. “information and guidance on complementary therapies”, 
“relaxation”, “nutrition” and “exercise”, and specific physical concerns i.e. “fertility”, 
“lymphedema” and “hot flushes and night sweats”.  
 
MYCaW Concern items that could not be found on FACIT-SpEx were searched for 
on other cancer related PROMs. There was no instrument identified that contained all 
of the MYCaW Concern categories.  Nine instruments were identified which 
measured  one or more aspects of QoL (e.g physical, psychological, social, and 
spiritual) and containing one or more of the  outstanding MYCaW Concerns: (POMS 
[27], SF-36 [28], CARES-SF [29], EORTC QLQ-C30 [30], QLI-CV [31], FACIT-
SpEx [22], EQ-5D [32], QoL-CS [33] QLACS [34]).  One tool the Distress 
Thermometer [35] was also identified which represented some outstanding MYCaW 







This article reports on the first type of validity assessment of MYCaW, which 
specifically included the responsiveness, generalizability, and content and convergent 
validity of MYCaW.  The data set(s) used for this study represents the experiences of 
cancer patients who seek complementary and integrative cancer care, the target 
population for this outcome measure.  The Analysis has demonstrated that MYCaW 
scores are highly responsive to change, the qualitative coding framework is 
generalizable across 2 different CIM oncology settings and MYCaW has the ability to 
capture a wide range of patient-identified concerns as compared to existing cancer-
related PROMs. 
 
Validation of MYCaW Score Changes 
FACIT is a well validated and commonly used tool for measuring HRQL in people 
with cancer and already has the minimally important difference in score changes 
defined [26]. For these reasons, FACIT-SpEx was used as a suitable tool against 
which to validate the responsiveness of MYCaW scores.  There was a high degree of 
correlation of baseline scores on the FACIT-SpEx and MYCaW questionnaires, 
highlighting good convergent validity of MYCaW.  As shown in Table 1, MYCAW 
score changes for Concern 1, Concern 2 and Profile scores are extremely responsive 
to capturing the person's experience of how their concerns change, and more so than 
FACIT-SpEx. This may be because the participants define their own items – the 
Concerns - for MYCaW, hence participants know exactly what the concern means to 
them and perhaps score it more accurately than a pre-determined item. The MYCaW 
Wellbeing score was less responsive to change, but the effect size still indicated a 
medium effect. The Wellbeing score is arguably more comparable to the total FACIT-
SpEx score in how a person perceives their Wellbeing as a total concept and 
interestingly the respective SRM and effect size scores highlight this (Table 1). The 
MYCaW SRMs were very similar to those achieved in the sister questionnaire, 
MYMOP, which was developed for general practice [24,25].  
 
To further understand the responsiveness of MYCaW scores, 4 different distribution 
based analyses were carried out, using the FACIT-SpEx questionnaire as an anchor 
(Table 3). The raw MYCaW scores and the responsiveness scores followed the 
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expected gradient when compared across the highest and lowest FACIT-SpEx 
categories of clinical change. By splitting the sample into categories of clinical 
change, the authors acknowledge that the numbers in each group are much smaller 
and that the standard deviation is larger, which may affect the accuracy of the 
responsiveness calculations [36, 37].  Also there were not enough participants with 
clinically relevant deterioration to carry out meaningful analysis.  
 
Generalisability of the Qualitative Analysis Framework 
The original MYCaW qualitative analysis frameworks were devised using UK data 
from 3 geographical locations and where participants were using the NHS as their 
primary treatment provider.  MYCaW is used in many complementary and integrative 
cancer centres internationally, which incorporate a range of healthcare models. 
Therefore, it was important to determine whether any amendments to the analysis 
framework would be necessary to accommodate more integrated models of care led 
by naturopathic doctors.  Patients are primarily female, with a range of diagnoses of 
advanced cancer. Data collected at the OICC may therefore represent different types 
of patient concerns than data collected in United Kingdom as part of MYCaW 
development.  The generalizability analysis demonstrated that the majority of 
categories within the prior qualitative analysis framework were transferable to the 
OICC, although additional categories were added, including ones for spiritual 
Wellbeing, weight change, specific side effects from hospital treatment relating to 
surgery and radiotherapy, and practical concerns relating to finances and work (Table 
4). Levels of spiritual Wellbeing are known to correlate to total Wellbeing [38] and as 
the use of holistic models of care increases, measuring the effect of CIM on spiritual 
Wellbeing is very important. Similarly there is a growing acknowledgement of the 
financial burden of cancer and how diagnosis and treatment has a profound effect of 
practical issues for many members of the family [39].   The assessment of 
generalizability across a total of 4 different CIM centres, including resultant 
refinements to the qualitative analysis framework, suggests that MYCaW is broadly 
applicable across different settings.  People seeking care at OICC and PBCC are 
representative of the broader population of people seeking complementary and 
integrative cancer care, who are more commonly female, of middle age with 
advanced diagnoses.  While the MYCaW coding framework appears generalizable 
across these centers, the authors acknowledge the need for similar generalizability 
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assessments across a greater range of countries, cultures and models of CIM care.  
The authors would welcome collaborations with other CIM centres who use MYCaW 
and would like to contribute to such analyses. 
 
There was high construct validity when correlating FACIT-SpEx scores with 
MYCaW scores. It was notable, however, that several MYCaW Concerns were 
neither represented on FACIT-SpEx, nor on other commonly used HRQL tools. 
Concerns about healing and arm problems were not represented cancer based HRQL 
tools, or tools used as clinical decision making aids. Whilst some questionnaires have 
bolt-on subscales which may cover lymophodema, when evaluating a heterogeneous 
sample of participants, it is necessary to be able to identify all relevant concerns 
quickly and simply. Furthermore, Concerns data on MYCaW associated with arm 
problems covered issues such as restricted movement, not just lymphedema.  
Concerns relating to relaxation, guidance on complementary therapies, nutrition 
(relating to knowing what foods are best to eat, as opposed to side effects around 
eating problems) and lympoedema could only be found on clinical aid tools, such as 
the Distress Thermometer [35] and other holistic assessment tools [40]. It is 
noticeable that these types of concerns tended to be less about medical issues and 
more about what the patient could be doing to support themselves. While patients are 
able to access information on the internet and hear about potential avenues to support 
themselves, they are very vulnerable to accessing and following unevidenced 
approaches.   It is also noteworthy that during treatment in many hospitals it is 
variable as to whether these areas of concerns relating to nutrition, healing, relaxation 
or guidance on CAM are even discussed.  It is our observation that if a patient reports 
their top 2 concerns as hot flushes and access to information about complementary 
therapy for instance, then it is likely that these concerns are so severe, that the person 
needs professional support and the concerns will not just improve over time. 
Therefore, whilst a clinician may not perceive these issues as life-threatening or a 
priority in the patient's treatment plan, for the patient these concerns are likely to be 
causing them a degree of distress or anxiety and do need discussing. 
 
The growing use of CIM in cancer treatment and support means that tools being used 
for researching the effectiveness of these models of care, need to capture all the 
variables relevant to patients for meaningful data analysis to be performed.  So while 
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there are a plethora of tools to assess and measure patient reported outcomes, there are 
very few that are being used in research that fully represent all the items that are 
important to patients. Furthermore, failure to measure all outcomes relevant to 
patients will lead to a bias in the reporting in effectiveness of CIM healthcare models. 
 
MYCAW to Personalise Approach 
MYCaW was developed in response to the need for cancer centres offering 
complementary supportive care to people with cancer and their supporters/carers, to 
be able to document fundamental reasons why patients were using their service (as an 
extra to the treatment already received in the NHS), to develop a method of quickly 
determining the most pressing concerns to be addressed (as a clinical assessment tool 
to compliment the holistic medical history) and to quantify whether after a series of 
therapy sessions the patient felt that the severity of their concerns had decreased. 
Further data was collected on follow-up, to understand what else a person thought 
may also affect their health, and what was most important about the centre visited.  
As with any organisation, optimizing the service provided to best meet the needs of 
the users is fundamental to success of the patient outcomes. 
 
One limitation of MYCaW is that it cannot be used solely to measure quality of life, 
as the tool only measures the main concerns a patient has and does not compare the 
same list of items for each person.  Therefore MYCaW is not intended to be used to 
replace a quality of life outcomes measure, more as an adjunct in these circumstances, 
as it can capture concerns that are important to the patient that may not be listed on 
the quality of life measure.  Furthermore, this article only reports on some validity 
analysis of MYCaW.  There are other aspects of psychometric analyses that have not 
yet been carried out that could further determine how well MYCaW performs. 
 
In summary, MYCAW is fast to administer, is suitable for use with a heterogeneous 
group of patients,  can be routinely incorporated into clinical administration processes 
and  is responsive to change.  Concerns data can determine a patient's primary needs 
and facilitate a more personalized service to be offered. MYCAW data can determine 
why patients use a service, how they respond to treatment and what aspects of the 
service are beneficial. Such information can be used to inform future pathways of care 
and use funding efficiently. The analysis framework allows comparison of data 
16 
 
internationally and is suitable for a range of CIM healthcare models.  As a research 
tool, MYCaW is a valuable addition alongside other validated HRQL tools to ensure 
that all patient variables have been captured.  These data can inform a more accurate 
design and analysis of  comparative effectiveness research.  Finally, as cancer 
treatments increasingly incorporate CIM, MYCaW allows holistic concerns to be 
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Table 1: Scores, score changes, Standardised Response Means (SRM) and effect 
size for all MYCaW scores and FACIT-SpEx. * Concern 2 is optional hence n=79. 








Concern 1 82 4.66 (1.15) 3.21 (1.36) 1.45 (1.42) 1.02 1.26 
Concern 2* 79 4.23 (1.08) 2.90 (1.29) 1.33 (1.43) 0.93 1.23 
Wellbeing 82 2.73 (1.2) 2.15 (1.26) 0.59 (1.19) 0.5 0.49 
Profile 82 3.86 (0.91) 2.75 (1.03) 1.11 (1.03) 1.08 1.22 
FACIT-
SpEx 

























































Table 2: Mean change scores for MYCaW Concern 1, Concern 2, Wellbeing and 
Profile Score, stratified by degree of change on FACIT-SpEx SI: substantial 
improvement; CRI: clinically relevant improvement; CRD: clinically relevant 
deterioration; SD: substantial deterioration. 
Category 
Criteria 























































Table 3: T statistics, effect size, Guyatt response score and standardised response 
mean for MYCaW according to degree of change on FACIT-SpEx SI: substantial 
improvement; CRI: clinically relevant improvement; CRD: clinically relevant 











  MYCaW Concern 1 
SI 29 1.29 1.66 1.28 1.40 
CRI 12 0.76 0.79 0.76 0.82 
Stable 28 1.08 1.44 1.08 1.08 
CRD 2 Not calculated 
SD 11 0.45 0.54 0.45 0.39 
  MYCaW Concern 2 
SI 28 1.1 1.33 1.5 0.89 
CRI 12 0.64 1.18 0.88 0.79 
Stable 27 1.03 1.44 1.41 1.41 
CRD 2 Not calculated 
SD 10 0.63 0.74 0.86 0.62 
  MYCaW Wellbeing 
SI 29 0.87 0.79 0.88 0.94 
CRI 12 0.56 0.85 0.57 1.03 
Stable 28 0.39 0.37 0.39 0.39 
CRD 2 not calculated    
SD 11 -0.15 -0.16 -0.15 -0.13 
  MYCaW Profile 
SI 29 1.43 1.53 1.55 1.56 
CRI 12 0.86 1.14 0.94 1.1 
Stable 28 1.12 1.31 1.21 1.21 
CRD 2 Not calculated    
SD 11 0.43 0.45 0.46 0.33 
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Table 4: Changes made to qualitative analysis guidelines for MYCaW: Go to 
http://www.bris.ac.uk/primaryhealthcare/resources/mymop/sisters/ to download the 
qualitative analysis guidelines 
MYCaW 
Supercategory 
NEW categories added  
S2 Physical Concerns   S2g 'Recurrence and spread' split into two separate 
categories - S2f 'recurrence' and S2g 'spread' 
 S2h 'Weight change' 
 
S3 Hospital cancer  
treatment Concerns 
 S3d 'Side effects of surgery' and S3e 'Side effects of 
radiotherapy' 
 S3b 'Lymphoedema' now under S3d 'Side effects of 
surgery' 





 S4g 'Spiritual Wellbeing - meaning and peace' and 
S4h 'Spiritual Wellbeing - faith' 
 S4b 'General Wellbeing' inclusion criteria amended to 
include references to preventing the development of 
primary cancer 
S5 Practical Concerns Creation of new category S5 'Practical Concerns' - 
includes S5a finance and S5b work 
 
 
 
